Worth Venture Partners, LLC Cognition Therapeutics Inc Transaction History

Worth Venture Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.56 - $3.38 $10,920 - $23,660	7,000 Added 1.4%	508,719 $930,000
Q4 2022 Feb 14, 2023	BUY	$1.17 - $3.51 $352,791 - $1.06 Million	301,531 Added 150.62%	501,719 $1.05 Million
Q3 2022 Nov 14, 2022	SELL	$1.63 - $3.6 $45,610 - $100,735	-27,982 Reduced 12.26%	200,188 $380,000
Q2 2022 Aug 15, 2022	BUY	$1.5 - $3.45 $79,206 - $182,173	52,804 Added 30.11%	228,170 $459,000
Q1 2022 May 16, 2022	BUY	$2.41 - $6.9 $422,632 - $1.21 Million	175,366 New	175,366 $473,000

6.58M

Ticker CGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,710,700
Market Cap $13.2M
Description
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.